Wave Life Sciences, Inc ARS, filed Oct 14, 2026

Wave Life Sciences, Inc. (WVE)

Wave Life Sciences Ltd. said WVE-007 dosing is underway in the Phase 2a INLIGHT™ trial, while a WVE-008 clinical trial application is planned for the second half of 2026. AI summary